Abstract Number ‐ 134: How far can we go? WEB technology for the treatment of sidewall IA. Single Institution.

IF 2.1 Q3 CLINICAL NEUROLOGY
B. Pabón, V. Torres, M. Patiňo, J. Peláez, J. Mútis, M. Cardozo
{"title":"Abstract Number ‐ 134: How far can we go? WEB technology for the treatment of sidewall IA. Single Institution.","authors":"B. Pabón, V. Torres, M. Patiňo, J. Peláez, J. Mútis, M. Cardozo","doi":"10.1161/svin.03.suppl_1.134","DOIUrl":null,"url":null,"abstract":"\n \n Few years after introduction, Flow disruption technology using WEB device has been used safely for the treatment of wide‐neck bifurcation aneurysms, but the use of this endosaccular approach to treat side‐wall lesions in terms of feasibility, safety, stability and aneurysm occlusion rate after this treatment is unknown.\n \n \n \n Patients were carefully selected. IRB approved. Clinical, anatomical, angiographical and technical considerations were analyzed. Procedure related complications, procedural time, antiplatelet therapy requirements. Web Occlusion Scale (WOS) was used for the Follow‐up.\n \n \n \n From August 2017 and March 2021 a total of 14 wide‐necked, sidewall, IA were selected for WEB treatment. Aneurysm mean size 5.3mm in width and 5.8 in height. Aneurysm Location: ICA 8 cases (five PComA, two Carotid‐ophtalmic segment, one AChoA segment), Superior Cerebellar Artery SCA in 5 patients (35%), and one impressive case in posterior circulation associated with a basilar fenestration next to VBJ. Eight cases were unruptured (57%), and six cases with history of SAH‐ acute setting. DAPT used pre operatively in all elective cases but none patient remain under antiplatelets after procedure. Technical success of 100%. Mean procedure time: 24 min. None related procedure complications recorded. Immediately angiographic occlusion was evidenced in 9 cases. Radiological Follow up (ranging 1‐ 26 months) available in 9/14 showed a WOS adequate occlusion in all cases.\n \n \n \n In our early experience using WEB device to treat different conditions than bifurcation IA´s, the results showed that endossacular approach was feasible in highly selected patients, safety profile in agreement with previous bifurcation experiences and very effective to treat challenge cases with a high probability of recurrence or therapeutic failure. Larger series and controlled studies are required to expand its indications in a near future.\n","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke (Hoboken, N.J.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/svin.03.suppl_1.134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Few years after introduction, Flow disruption technology using WEB device has been used safely for the treatment of wide‐neck bifurcation aneurysms, but the use of this endosaccular approach to treat side‐wall lesions in terms of feasibility, safety, stability and aneurysm occlusion rate after this treatment is unknown. Patients were carefully selected. IRB approved. Clinical, anatomical, angiographical and technical considerations were analyzed. Procedure related complications, procedural time, antiplatelet therapy requirements. Web Occlusion Scale (WOS) was used for the Follow‐up. From August 2017 and March 2021 a total of 14 wide‐necked, sidewall, IA were selected for WEB treatment. Aneurysm mean size 5.3mm in width and 5.8 in height. Aneurysm Location: ICA 8 cases (five PComA, two Carotid‐ophtalmic segment, one AChoA segment), Superior Cerebellar Artery SCA in 5 patients (35%), and one impressive case in posterior circulation associated with a basilar fenestration next to VBJ. Eight cases were unruptured (57%), and six cases with history of SAH‐ acute setting. DAPT used pre operatively in all elective cases but none patient remain under antiplatelets after procedure. Technical success of 100%. Mean procedure time: 24 min. None related procedure complications recorded. Immediately angiographic occlusion was evidenced in 9 cases. Radiological Follow up (ranging 1‐ 26 months) available in 9/14 showed a WOS adequate occlusion in all cases. In our early experience using WEB device to treat different conditions than bifurcation IA´s, the results showed that endossacular approach was feasible in highly selected patients, safety profile in agreement with previous bifurcation experiences and very effective to treat challenge cases with a high probability of recurrence or therapeutic failure. Larger series and controlled studies are required to expand its indications in a near future.
摘要编号134:我们能走多远?WEB技术用于处理侧壁IA。单一的机构。
引入WEB装置后的几年,血流阻断技术已被安全地用于治疗宽颈分叉动脉瘤,但使用这种囊内入路治疗侧壁病变的可行性、安全性、稳定性和治疗后的动脉瘤闭塞率尚不清楚。病人是经过精心挑选的。IRB批准。分析了临床、解剖、血管造影和技术方面的考虑。手术相关并发症,手术时间,抗血小板治疗要求。采用Web Occlusion Scale (WOS)进行随访。从2017年8月到2021年3月,共选择14只宽颈、侧壁、IA进行WEB治疗。动脉瘤平均尺寸宽5.3mm,高5.8 mm。动脉瘤位置:ICA 8例(5例PComA, 2例颈-眼段,1例颈前动脉段),5例小脑上动脉SCA(35%), 1例后循环伴基底动脉开窗,靠近VBJ。8例未破裂(57%),6例有急性SAH病史。所有选择性病例术前均使用DAPT,但术后无患者继续使用抗血小板药物。技术成功率100%。平均手术时间24分钟,无相关手术并发症记录。9例即刻血管造影证实闭塞。2014年9月的放射学随访(1 - 26个月)显示,所有病例的WOS都有足够的闭塞。在我们的早期经验中,使用WEB设备治疗不同于分岔IA的情况,结果表明,在高度选择的患者中,囊内入路是可行的,安全性与以前的分岔经验一致,对于治疗复发或治疗失败概率高的挑战病例非常有效。在不久的将来,需要更大规模的系列和对照研究来扩大其适应症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信